@article{gong_analysis_2024,
	title = {Analysis of effectiveness of pharmaceutical services using enterprise {WeChat} for outpatients with cancer pain},
	volume = {26},
	issn = {1008-5734},
	url = {https://www.embase.com/search/results?subaction=viewrecord&id=L2031064583&from=export},
	doi = {10.3760/cma.j.cn114015-20230904-00655},
	abstract = {Objective To explore the effects of pharmaceutical services through enterprise WeChat for outpatients with cancer pain. Methods A retrospective study was conducted on patients who were first diagnosed and/or previously treated for cancer pain and visited Outpatient Department of the First Affiliated Hospital of Soochow University from January 1, 2020 to January 30, 2023. The outpatients were divided into conventional pharmaceutical services management group (conventional group) and pharmaceutical services management group through enterprise WeChat (enterprise WeChat group) based on whether they received pharmaceutical services for cancer pain through enterprise WeChat. Prescription appropriateness, changes in cancer pain and life quality evaluation indicators after treatment in patients between the 2 groups were recorded and compared. Results A total of 174 patients were included, with 87 patients in each group. There were no significant differences in age and gender between the 2 groups (all P{\textgreater}0.05). Before the pharmaceutical services management for cancer pain through enterprise WeChat, the differences in the proportion of patients with pain free, mild, moderate, and severe pain after pain relief treatments between the 2 groups were not significant (all P{\textgreater}0.05). In the conventional group, 13 out of 87 patients (14.9\%) had inappropriate prescriptions, and 2 out of 87 (2.3\%) in the enterprise WeChat group, with statistically significant difference (χ2=8.828, P{\textless}0.05). After management with enterprise WeChat, the patients of pain-free increased from 19 to 55 (63.2\%) in the enterprise WeChat group, and from 18 to 41 (47.1\%) in the conventional group. The difference in the proportion of pain-free patients between the 2 groups was statistically significant (χ2 =4.555, P=0.033). The differences in the scores of various indicators of life quality between the 2 groups before management with enterprise WeChat were not significant (all P{\textgreater}0.05). After the management with enterprise WeChat, life quality scores in all the 8 dimensions were significantly higher than those in the conventional group (all P{\textless}0.05). Conclusion The utilization of enterprise WeChat could improve the treatment effect of cancer pain, enhance their life quality, help improve the quality of pharmaceutical services, and have certain promotion and utilization value.},
	language = {Chinese},
	number = {2},
	journal = {Adverse Drug Reactions Journal},
	author = {Gong, X. and Zheng, X. and Yu, X. and Cao, X.},
	year = {2024},
	keywords = {age, analgesia, article, cancer pain, cancer patient, clinical effectiveness, commercial phenomena, controlled study, gender, human, major clinical study, outpatient, pharmacy (shop), prescribing error, prescription, quality of life, retrospective study, social media},
	pages = {101--105},
}

{"_id":"pTDgj8pBhqPXS2ECD","bibbaseid":"gong-zheng-yu-cao-analysisofeffectivenessofpharmaceuticalservicesusingenterprisewechatforoutpatientswithcancerpain-2024","author_short":["Gong, X.","Zheng, X.","Yu, X.","Cao, X."],"bibdata":{"bibtype":"article","type":"article","title":"Analysis of effectiveness of pharmaceutical services using enterprise WeChat for outpatients with cancer pain","volume":"26","issn":"1008-5734","url":"https://www.embase.com/search/results?subaction=viewrecord&id=L2031064583&from=export","doi":"10.3760/cma.j.cn114015-20230904-00655","abstract":"Objective To explore the effects of pharmaceutical services through enterprise WeChat for outpatients with cancer pain. Methods A retrospective study was conducted on patients who were first diagnosed and/or previously treated for cancer pain and visited Outpatient Department of the First Affiliated Hospital of Soochow University from January 1, 2020 to January 30, 2023. The outpatients were divided into conventional pharmaceutical services management group (conventional group) and pharmaceutical services management group through enterprise WeChat (enterprise WeChat group) based on whether they received pharmaceutical services for cancer pain through enterprise WeChat. Prescription appropriateness, changes in cancer pain and life quality evaluation indicators after treatment in patients between the 2 groups were recorded and compared. Results A total of 174 patients were included, with 87 patients in each group. There were no significant differences in age and gender between the 2 groups (all P\\textgreater0.05). Before the pharmaceutical services management for cancer pain through enterprise WeChat, the differences in the proportion of patients with pain free, mild, moderate, and severe pain after pain relief treatments between the 2 groups were not significant (all P\\textgreater0.05). In the conventional group, 13 out of 87 patients (14.9%) had inappropriate prescriptions, and 2 out of 87 (2.3%) in the enterprise WeChat group, with statistically significant difference (χ2=8.828, P\\textless0.05). After management with enterprise WeChat, the patients of pain-free increased from 19 to 55 (63.2%) in the enterprise WeChat group, and from 18 to 41 (47.1%) in the conventional group. The difference in the proportion of pain-free patients between the 2 groups was statistically significant (χ2 =4.555, P=0.033). The differences in the scores of various indicators of life quality between the 2 groups before management with enterprise WeChat were not significant (all P\\textgreater0.05). After the management with enterprise WeChat, life quality scores in all the 8 dimensions were significantly higher than those in the conventional group (all P\\textless0.05). Conclusion The utilization of enterprise WeChat could improve the treatment effect of cancer pain, enhance their life quality, help improve the quality of pharmaceutical services, and have certain promotion and utilization value.","language":"Chinese","number":"2","journal":"Adverse Drug Reactions Journal","author":[{"propositions":[],"lastnames":["Gong"],"firstnames":["X."],"suffixes":[]},{"propositions":[],"lastnames":["Zheng"],"firstnames":["X."],"suffixes":[]},{"propositions":[],"lastnames":["Yu"],"firstnames":["X."],"suffixes":[]},{"propositions":[],"lastnames":["Cao"],"firstnames":["X."],"suffixes":[]}],"year":"2024","keywords":"age, analgesia, article, cancer pain, cancer patient, clinical effectiveness, commercial phenomena, controlled study, gender, human, major clinical study, outpatient, pharmacy (shop), prescribing error, prescription, quality of life, retrospective study, social media","pages":"101–105","bibtex":"@article{gong_analysis_2024,\n\ttitle = {Analysis of effectiveness of pharmaceutical services using enterprise {WeChat} for outpatients with cancer pain},\n\tvolume = {26},\n\tissn = {1008-5734},\n\turl = {https://www.embase.com/search/results?subaction=viewrecord&id=L2031064583&from=export},\n\tdoi = {10.3760/cma.j.cn114015-20230904-00655},\n\tabstract = {Objective To explore the effects of pharmaceutical services through enterprise WeChat for outpatients with cancer pain. Methods A retrospective study was conducted on patients who were first diagnosed and/or previously treated for cancer pain and visited Outpatient Department of the First Affiliated Hospital of Soochow University from January 1, 2020 to January 30, 2023. The outpatients were divided into conventional pharmaceutical services management group (conventional group) and pharmaceutical services management group through enterprise WeChat (enterprise WeChat group) based on whether they received pharmaceutical services for cancer pain through enterprise WeChat. Prescription appropriateness, changes in cancer pain and life quality evaluation indicators after treatment in patients between the 2 groups were recorded and compared. Results A total of 174 patients were included, with 87 patients in each group. There were no significant differences in age and gender between the 2 groups (all P{\\textgreater}0.05). Before the pharmaceutical services management for cancer pain through enterprise WeChat, the differences in the proportion of patients with pain free, mild, moderate, and severe pain after pain relief treatments between the 2 groups were not significant (all P{\\textgreater}0.05). In the conventional group, 13 out of 87 patients (14.9\\%) had inappropriate prescriptions, and 2 out of 87 (2.3\\%) in the enterprise WeChat group, with statistically significant difference (χ2=8.828, P{\\textless}0.05). After management with enterprise WeChat, the patients of pain-free increased from 19 to 55 (63.2\\%) in the enterprise WeChat group, and from 18 to 41 (47.1\\%) in the conventional group. The difference in the proportion of pain-free patients between the 2 groups was statistically significant (χ2 =4.555, P=0.033). The differences in the scores of various indicators of life quality between the 2 groups before management with enterprise WeChat were not significant (all P{\\textgreater}0.05). After the management with enterprise WeChat, life quality scores in all the 8 dimensions were significantly higher than those in the conventional group (all P{\\textless}0.05). Conclusion The utilization of enterprise WeChat could improve the treatment effect of cancer pain, enhance their life quality, help improve the quality of pharmaceutical services, and have certain promotion and utilization value.},\n\tlanguage = {Chinese},\n\tnumber = {2},\n\tjournal = {Adverse Drug Reactions Journal},\n\tauthor = {Gong, X. and Zheng, X. and Yu, X. and Cao, X.},\n\tyear = {2024},\n\tkeywords = {age, analgesia, article, cancer pain, cancer patient, clinical effectiveness, commercial phenomena, controlled study, gender, human, major clinical study, outpatient, pharmacy (shop), prescribing error, prescription, quality of life, retrospective study, social media},\n\tpages = {101--105},\n}\n\n\n\n","author_short":["Gong, X.","Zheng, X.","Yu, X.","Cao, X."],"key":"gong_analysis_2024","id":"gong_analysis_2024","bibbaseid":"gong-zheng-yu-cao-analysisofeffectivenessofpharmaceuticalservicesusingenterprisewechatforoutpatientswithcancerpain-2024","role":"author","urls":{"Paper":"https://www.embase.com/search/results?subaction=viewrecord&id=L2031064583&from=export"},"keyword":["age","analgesia","article","cancer pain","cancer patient","clinical effectiveness","commercial phenomena","controlled study","gender","human","major clinical study","outpatient","pharmacy (shop)","prescribing error","prescription","quality of life","retrospective study","social media"],"metadata":{"authorlinks":{}},"html":""},"bibtype":"article","biburl":"https://bibbase.org/zotero/katiedillon","dataSources":["Qf74gub9z54CooHnE"],"keywords":["age","analgesia","article","cancer pain","cancer patient","clinical effectiveness","commercial phenomena","controlled study","gender","human","major clinical study","outpatient","pharmacy (shop)","prescribing error","prescription","quality of life","retrospective study","social media"],"search_terms":["analysis","effectiveness","pharmaceutical","services","using","enterprise","wechat","outpatients","cancer","pain","gong","zheng","yu","cao"],"title":"Analysis of effectiveness of pharmaceutical services using enterprise WeChat for outpatients with cancer pain","year":2024}